NCT07689565

Brief Summary

This randomized controlled trial aims to compare the efficacy and safety of a Flexible and Navigable Suction Ureteral Access Sheath (FANS) versus a standard ureteral access sheath during flexible ureterorenoscopy (FURS) in pediatric patients with renal stones less than 2 cm. The study will evaluate stone-free rates. operative time. intraoperative parameters. operative and postoperative complication and the need for any auxiliary procedures. Sixty pediatric patients will be randomly allocated into two equal groups and treated at the Urology Department, Tanta University.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Jun 2026Jun 2027

First Submitted

Initial submission to the registry

June 30, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

June 30, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 8, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

July 8, 2026

Status Verified

June 1, 2026

Enrollment Period

11 months

First QC Date

June 30, 2026

Last Update Submit

July 6, 2026

Conditions

Keywords

Flexible UreterorenoscopyRetrograde Intrarenal SurgeryUreteral Access SheathSuction-Assisted UreteroscopyPediatric Urology

Outcome Measures

Primary Outcomes (1)

  • Stone-free rate (SFR)

    Absence of residual fragments or presence of clinically insignificant residual fragments measuring \< 3 mm, assessed by postoperative CT scan.

    1 month postoperatively

Secondary Outcomes (6)

  • Operative time

    Intraoperatively . from insertion of sheath

  • Intraoperative visibility and ease of access

    intraoperatively

  • Intraoperative complications

    intraoperatively

  • Postoperative complications

    up to 30 days postoperatively

  • Need for auxiliary procedures.

    up to 30 days postoperatively

  • +1 more secondary outcomes

Study Arms (2)

Group A: Standard UAS

ACTIVE COMPARATOR

Standard UAS (Length: 28-35 cm, Size: 10/12 Fr or 9.5/11.5 Fr) used during flexible ureteroscopic stone fragmentation using Holmium:YAG laser.

Device: Standard Ureteral Access Sheath (Boston Scientific).

Group B: Suction UAS (FAAN)

EXPERIMENTAL

Suction evacuation ureteral access sheath (Length: 30-35 cm, Size: 10/12 Fr or 11/13 Fr) with terminal flexible end enabling continuous drainage and suction during laser stone fragmentation

Device: Flexible and Navigable Suction UAS (ClearPetra).

Interventions

Standard UAS (Length: 28-35 cm, Size: 10/12 Fr or 9.5/11.5 Fr)

Group A: Standard UAS

Suction evacuation ureteral access sheath (Length: 30-35 cm, Size: 10/12 Fr or 11/13 Fr) with terminal flexible end

Group B: Suction UAS (FAAN)

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pediatric patients (age ≤ 18 years)
  • Patients with renal stones less than 2 cm
  • Indicated for flexible ureterorenoscopy
  • Fit for general anesthesia
  • Informed consent obtained from parents or guardians

You may not qualify if:

  • Stones larger than 2 cm
  • Active urinary tract infection
  • Congenital urinary tract anomalies affecting access
  • Previous ureteral surgery affecting the ureter
  • Coagulopathy or unfit for surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, Gharbia Governorate, 31527, Egypt

Location

MeSH Terms

Conditions

Kidney CalculiNephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • salah abdelmnsef nagla, MD-PHD

    Tanta unversity

    STUDY CHAIR
  • osama mostafa elgamal, MD-PHD

    Tanta unversity

    STUDY DIRECTOR
  • Mohamed ebrahim elmaadawy, MD-PHD

    Tanta unversity

    STUDY DIRECTOR

Central Study Contacts

khaled Mostafa elmaradney, MD

CONTACT

mohamed ebrahim elmaadawy, MD.PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible pediatric patients will be randomly allocated into two equal parallel groups (1:1 ratio). Group A will undergo flexible ureterorenoscopy (FURS) using a standard ureteral access sheath (UAS), while Group B will undergo FURS using a flexible and navigable suction ureteral access sheath (FANS). Both groups will be followed up postoperatively to compare efficacy and safety outcomes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident of Urology, Damanhour Teaching Hospital, Egypt

Study Record Dates

First Submitted

June 30, 2026

First Posted

July 8, 2026

Study Start

June 30, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

July 8, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations